- Home
- PFE vs BSX Comparison
PFE vs BSX Comparison
Compare PFE & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFE
- BSX
- Stock Information
- Founded
- PFE 1849
- BSX 1979
- Country
- PFE United States
- BSX United States
- Employees
- PFE N/A
- BSX N/A
- Industry
- PFE Biotechnology: Pharmaceutical Preparations
- BSX Medical/Dental Instruments
- Sector
- PFE Health Care
- BSX Health Care
- Exchange
- PFE Nasdaq
- BSX Nasdaq
- Market Cap
- PFE N/A
- BSX 129.7B
- IPO Year
- PFE N/A
- BSX 1992
- Fundamental
- Price
- PFE $25.70
- BSX $103.60
- Analyst Decision
- PFE Buy
- BSX Strong Buy
- Analyst Count
- PFE 14
- BSX 23
- Target Price
- PFE $31.92
- BSX $107.23
- AVG Volume (30 Days)
- PFE 56.3M
- BSX 8.3M
- Earning Date
- PFE 04-29-2025
- BSX 04-23-2025
- Dividend Yield
- PFE 6.73%
- BSX N/A
- EPS Growth
- PFE 284.33
- BSX 16.82
- EPS
- PFE 1.41
- BSX 1.25
- Revenue
- PFE $63,627,000,000.00
- BSX $16,747,000,000.00
- Revenue This Year
- PFE $0.06
- BSX $15.51
- Revenue Next Year
- PFE $0.13
- BSX $10.31
- P/E Ratio
- PFE $18.10
- BSX $82.48
- Revenue Growth
- PFE 6.84
- BSX 17.61
- 52 Week Low
- PFE $24.48
- BSX $66.80
- 52 Week High
- PFE $31.54
- BSX $107.17
- Technical
- Relative Strength Index (RSI)
- PFE 48.35
- BSX 58.73
- Support Level
- PFE $25.89
- BSX $99.30
- Resistance Level
- PFE $26.52
- BSX $102.01
- Average True Range (ATR)
- PFE 0.47
- BSX 2.35
- MACD
- PFE 0.01
- BSX 0.54
- Stochastic Oscillator
- PFE 30.75
- BSX 98.36
About BSX Boston Scientific Corporation
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.